Gemina Laboratories (XCNQ:GLAB) EPS (Basic) : C$-0.07 (TTM As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories EPS (Basic)?

Gemina Laboratories's basic earnings per share (Basic EPS) for the three months ended in Jan. 2024 was C$-0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.07.

Gemina Laboratories's EPS (Diluted) for the three months ended in Jan. 2024 was C$-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.07.

Gemina Laboratories's EPS without NRI for the three months ended in Jan. 2024 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was -0.07.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Gemina Laboratories EPS (Basic) Historical Data

The historical data trend for Gemina Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories EPS (Basic) Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

EPS (Basic)

-0.10

-0.07

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EPS (Basic)	Get a 7-Day Free Trial							-0.03	-0.02	-0.02	-0.02	-0.01

Gemina Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Gemina Laboratories's Basic EPS for the fiscal year that ended in Jan. 2024 is calculated as

Basic EPS (A: Jan. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-5.217	-	0)	/	72.453
	=	-0.07

Gemina Laboratories's Basic EPS for the quarter that ended in Jan. 2024 is calculated as

Basic EPS (Q: Jan. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.762	-	0)	/	75.057
	=	-0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.07

Gemina Laboratories (XCNQ:GLAB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Gemina Laboratories EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

GLABF:USA

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.

Executives

James Damian Tansey

Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines